Braftovi Regimen Is Promising in Metastatic Colorectal Cancer
网页20 小时之前 · The BREAKWATER trial assessed the combination of Braftovi and Erbitux with or without chemotherapy in patients with metastatic colorectal cancer. Patients must have confirmed stage 4 colorectal cancer harboring a BRAF V600E mutation. Patients were ineligible if they had tumors that are microsatellite instability-high or …
Navigating the ‘Ever-Evolving Trajectory’ of Metastatic Breast Cancer
网页14 小时之前 · Mendez added that multidisciplinary care that is often applied to patients with metastatic breast cancer is not “one size fits all.”. “We need to tailor the therapy to the specific characteristics of the tumor,” she said. “We have now so many ways that we can do that, either with tissue biopsy or liquid biopsy (with blood), tissue ...
CURE - Oncology & Cancer News for Patients & Caregivers
网页Boruzu Approved by FDA For Multiple Myeloma, Mantle Cell Lymphoma. By Alex Biese. September 6th 2024. CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
Targeted Therapy Outperforms Standard Care in Metastatic Solid …
网页3 天之前 · Patients with metastatic solid tumors who underwent comprehensive genome profiling to determine the best targeted treatment strategy tended to have improved outcomes compared with those who received standard of care, according to findings from the phase 2 ROME trial presented at the 2024 European Society for Medical Oncology Congress.. Per the National Cancer Institute, the cancer genome ...
Adaptive NSCLC Study Fails to Produce Improved Results, Clinical ...
网页2 天之前 · Stable disease was observed in 42.9% of patients in group A, 66.7% in group B, 57.1% in group C, 30% in group E, and 50% in the control group. “In the control [group] with [Taxotere], 31 patients were enrolled, but only 23 were treated mainly due to consent withdrawal,” Tomasini said. “Two [groups] had to be closed prematurely during the ...
Therapies for Some With Prostate Cancer Focuses on Reducing …
网页3 天之前 · Loaded 0%. Newer treatments for metastatic hormone-sensitive prostate cancer like Nubeqa (darolutamide) are being developed to potentially reduce side effects like cognitive impairment and fatigue, an expert said. CURE® sat down with Dr. Fred Saad, director of prostate cancer research at Montreal Cancer Institute and full professor in the ...
All News - Curetoday
网页Roger O’Donnell Has Lymphoma, ‘Love Is Blind’ Star Reveals Cancer During Pregnancy and More. Ashley Chan; Brielle Benyon. September 6th 2024. From Roger O’Donnell announcing his aggressive lymphoma diagnosis to “Love Is Blind’s” Shaina Hurley opening up about her cervical cancer while three months pregnant, here’s what’s ...
Leukemia | Oncology & Cancer News | CURE - Curetoday
网页2024年8月26日 · Leukemia. CURE’s leukemia page is a go-to resource for oncology news and updates in the world of leukemia Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in leukemia.
A 'Whole Different Ballgame' for Myeloma Treatment - Curetoday
网页2024年3月11日 · A 'Whole Different Ballgame' for Myeloma Treatment. The BCMA protein has become the primary target for treating multiple myeloma, resulting in longer survival and more manageable side effects. Cindy Brown has been in remission since she started taking the immunotherapy drug Tecvayli for multiple myeloma. For …
Calquence Shows Favorable Long-Term Outcomes in Treatment …
网页2020年6月4日 · Long-term data presented at the 2020 ASCO Virtual Scientific Program demonstrated that Calquence (acalabrutinib) is safe and effective in patients with treatment-naïve chronic lymphocytic leukemia, supporting its use in the front line setting in this population. “Targeted inhibition of Bruton's tyrosine kinase, or BTK, has improved clinical ...